SPD465

DRUG2 trials

Sponsors

Shire

Conditions

Attention Deficit Hyperactivity DisorderAttention-Deficit/Hyperactivity Disorder

Phase 2

The Safety and Efficacy of SPD465 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

CompletedNCT00928148

ShireAttention-Deficit/Hyperactivity Disorder

Start: 2004-06-14End: 2004-11-20Updated: 2021-06-03

Phase 3

A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving Simulators

WithdrawnNCT00458445

ShireAttention Deficit Hyperactivity Disorder

Start: 2007-04-30End: 2007-06-15Updated: 2021-07-06

Related Papers

A randomized, double-blind study of SHP465 mixed amphetamine salts extended-release in adults with ADHD using a simulated adult workplace design

Postgraduate Medicine2018-05-2910 citations